CN103893694A - Medicine for treating coronary heart diseases - Google Patents
Medicine for treating coronary heart diseases Download PDFInfo
- Publication number
- CN103893694A CN103893694A CN201410100271.4A CN201410100271A CN103893694A CN 103893694 A CN103893694 A CN 103893694A CN 201410100271 A CN201410100271 A CN 201410100271A CN 103893694 A CN103893694 A CN 103893694A
- Authority
- CN
- China
- Prior art keywords
- medicine
- boil
- radix
- medicinal liquid
- ingredients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicine for treating coronary heart diseases. The medicine comprises the following ingredients by weight: 4-8g of American ginseng, 18-22g of radix astragali, 13-17g of red sage, 1-5g of leech, 0.1-0.5g of storax, 8-12g of red orange, 8-12g of allium macrostemon, 8-12g of almond, 28-32g of trichosanthes kirilowii maxim, 1-5g of pinellia ternata, 13-17g of ligusticum wallichii, 10-14g of Chinese angelica, 10-14g of rhizoma cyperi and 8-12g of radix curcumae. The production process of the medicine comprises the following steps: putting the ingredients into a medicine pot; decocting the ingredients after the ingredients are soaked for 1 hour by using water, boiling by using big fire and then decocting the mixture for 40 minutes by using soft fire; filtering medical liquor; then decocting the leaves for 20 minutes after water is added; filtering medical liquor; mixing the medical liquor acquired through two steps; adding 0.2-0.4g of storax; and evenly stirring to acquire a finished product. By adopting various Chinese herbal medicines, the medicine disclosed by the invention has various pharmaceutical ingredients and has the advantages of quick effect, wide applicability to crowds, good medicine stability, significant effect, no recurrence after healing and no toxic and side effects, thereby removing worries of patients.
Description
Technical field: the present invention relates to a kind of Chinese patent medicine preparation, specifically nurse one's health heart equilibrium between yin and yang, reach a kind of medicine for the treatment of coronary heart disease that treatment coronary heart disease order ground is taken.
Background technology: along with the raising of living standards of the people, people put physical condition in critical positions.But the high overnutrition of the modern life, easily suffers from various affluenza, thereby form coronary disease disease.Coronary heart disease is the commonly encountered diseases of society, doctor trained in Western medicine think bad life style, phlegm-dampness constitution, surfeit greasy and surfeit flavour, stress excessive be the main cause that causes that this is sick.The coronary heart disease traditional Chinese medical science belongs to the sick category such as " angina pectoris ", " pained ", " thoracic obstruction ", " depletion syndrome " " stagnation of phlegm-damp ", heart governing blood and vessels, unable operation of agitating painstaking effort of insufficiency of heart-QI; Stagnation of phlegm-damp, hyperlipidemia, blood puckery obstructed make blood operation difficult and occur chest pain, myocardial ischemia or necrosis; PD, pathogen being excessive but vital QI weak, blood stasis increases the weight of, and the stasis of blood is stagnant heavier, healthy energy wound healing.And treat now the medicine of coronary disease disease, and major part has toxic and side effects, and price is more expensive, and therapeutic effect is undesirable.
Summary of the invention: the present invention is directed to the deficiencies in the prior art, provide one to there is QI invigorating, invigorate blood circulation, a kind of medicine for the treatment of coronary heart disease of circulation of qi promoting function.
The technical scheme that the present invention adopted is for achieving the above object: the amounts of components of this medicine is: Radix Panacis Quinquefolii 4-8g, Radix Astragali 18-22g, Radix Salviae Miltiorrhizae 13-17g, Hirudo 1-5g, Styrax 0.1-0.5g (taking after mixing it with water), Exocarpium Citri Rubrum 8-12g, Bulbus Allii Macrostemonis 8-12g, Semen Armeniacae Amarum 8-12g, Fructus Trichosanthis 28-32g, Rhizoma Pinelliae 1-5g, Rhizoma Chuanxiong 13-17g, Radix Angelicae Sinensis 10-14g, Rhizoma Cyperi 10-14g and Radix Curcumae 8-12g; Its processing technology is: said medicine is put into medicine pot, add water and must exceed medicine top levels 3cm, soak 1 hour, start to boil, first use big fire boiled, then boil 40 minutes with little fire, medicinal liquid is leached, endure out medicinal liquid 200ml first.Again add water and exceed medicine top levels 2cm, boil, boil 20 minutes time, leach medicinal liquid 200ml, twice medicinal liquid mixed, add Styrax 0.2-0.4g, stir finished product, in last filling and package bag, cold preservation warehouse-in.
Theory of Chinese medical science thinks, blood operation is among blood vessels, and circulation is more than, flows round without stopping.With the passing of time and blood " Longevity and Life Preservation " said: " qi being the governor of blood, the stagnation of QI.Gas has one expiration and inspiration not transport, and it is not all right that blood has one expiration and inspiration ".So syndrome of blood stasis inevitably involves gas, can cause not promoting the circulation of blood of gas because of the deficiency of vital energy or the stagnation of QI, form coronary heart disease, coronary heart disease is long-term chronic wasting diseases, is the unbalanced outward manifestations of the vital organs of the human body, belongs to tcm internal medicine apoplexy category.According to the pathogenesis of coronary heart disease, face card treatment with QI invigorating, invigorate blood circulation, the method for circulation of qi promoting.
The present invention combines the clinical common sympton of coronary heart disease, breaks current conventional treatments, taking Chinese medical theory as basis, study through clinical observation for many years, the continuous Improvement of prescription, amendment are supplemented, and according to its pathogeny, taked the treatment of eliminating pathogenic factor for supporting vital QI.In side with Radix Panacis Quinquefolii, Radix Astragali strongly invigorating primordial QI, the capable blood of gas, and blood stasis dispelling and just not hindering; Radix Salviae Miltiorrhizae, Hirudo, Radix Angelicae Sinensis blood circulation promoting and blood stasis dispelling stimulate the menstrual flow; The Rhizoma Pinelliae, Exocarpium Citri Rubrum, Bulbus Allii Macrostemonis, Semen Armeniacae Amarum, Fructus Trichosanthis reduce phlegm, promoting the circulation of QI eliminating stagnation is with the chest stuffiness relieving, and the loosening bowel to relieve constipation of also holding concurrently; Styrax is walked to alter, sensible dissipating depression of QI, the meridian dredging; Radix Curcumae, Rhizoma Cyperi, Rhizoma Chuanxiong promoting flow of QI and blood, to help blood.Full side plays the merit of righting QI invigorating, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain altogether.
The invention has the beneficial effects as follows: owing to having adopted several kinds of Chinese medicinal materials formulated, its goods include multi-medicament composition, rapid-action, the crowd that takes is wide, medicine stability good, be easy to carry, evident in efficacy, can cure rapidly coronary disease disease, and more, without recurrence, have no side effect, removed patient's trouble and worry.
1, our nourishing YIN YANG invigorating, the conditioning vital organs of the human body, make it the dynamic equilibrium that reaches new, positive fate and pathogenic wind spontaneous recovery.There is vertical rod to see the effect of shadow, can be widely used in clinical.
2, the our true essence that obtains Zhong Jing, mends the side of colluding, and in 1 year 2 years, coronary heart disease is significantly taken on a new look mostly.Effectively improve quality of life, determined curative effect, processing technology is simple, cost is low, cheap.Owing to adopting Chinese herb medicine to make, no pain after taking medicine, do not rebound.
3, side effect is little, safe and reliable, the medicine of general western medical treatment coronary heart disease, there is dizziness, headache, feel sick, vomiting, arthralgia, constipation, the side effect such as liver function injury, and need Long-term taking medicine, easily recurrence after drug withdrawal, and adopt the party to treat, patient is reflected well, 94% conditions of patients is cured or is clearly better, from clinical observation, this can reduce AMI patients serum Ang II.PIIINP.ALD and TGF β 1 level, increased SOD level, and can obviously improve LVEDV and LVEF, can obviously reduce clinical symptoms and syndrome of qi stagnation and blood stasis integration, alleviate clinical symptoms, improve late result, improve cardiac function, and the generation having no side effect.
Detailed description of the invention: embodiment 1, the amounts of components of this medicine is: Radix Panacis Quinquefolii 4-8g, Radix Astragali 18-22g, Radix Salviae Miltiorrhizae 13-17g, Hirudo 1-5g, Styrax 0.1-0.5g, Exocarpium Citri Rubrum 8-12g, Bulbus Allii Macrostemonis 8-12g, Semen Armeniacae Amarum 8-12g, Fructus Trichosanthis 28-32g, Rhizoma Pinelliae 1-5g, Rhizoma Chuanxiong 13-17g, Radix Angelicae Sinensis 10-14g, Rhizoma Cyperi 10-14g and Radix Curcumae 8-12g; Its processing technology is: said medicine is put into medicine pot, add water and must exceed medicine top levels 3cm, soak 1 hour, start to boil, first use big fire boiled, then boil 40 minutes with little fire, medicinal liquid is leached, endure out medicinal liquid 200ml first.Again add water and exceed medicine top levels 2cm, boil, boil 20 minutes time, leach medicinal liquid 200ml, twice medicinal liquid mixed, add Styrax 0.2-0.4g, stir finished product, in last filling and package bag, cold preservation warehouse-in.
Embodiment 2: the amounts of components of described medicine is: Radix Panacis Quinquefolii 6g, Radix Astragali 20g, Radix Salviae Miltiorrhizae 15g, Hirudo 3g, Styrax 0.3g, Exocarpium Citri Rubrum 10g, Bulbus Allii Macrostemonis 10g, Semen Armeniacae Amarum 10g, Fructus Trichosanthis 30g, Rhizoma Pinelliae 3g, Rhizoma Chuanxiong 15g, Radix Angelicae Sinensis 12g, Rhizoma Cyperi 12g and Radix Curcumae 10g; Its processing technology is: said medicine is put into medicine pot, add water and must exceed medicine top levels 3cm, soak 1 hour, start to boil, first use big fire boiled, then boil 40 minutes with little fire, medicinal liquid is leached, endure out medicinal liquid 200ml first.Again add water and exceed medicine top levels 2cm, boil, boil 20 minutes time, leach medicinal liquid 200ml, twice medicinal liquid mixed, add Styrax 0.3g, stir finished product, in last filling and package bag, cold preservation warehouse-in.
Embodiment 3: this drug administration method services once for dividing sooner or later, takes continuously 2 months.Can make coronary disease patient get well, and not recur for many years.
Embodiment 4: criterion of therapeutical effect
(1) cardiac function detects: adopt echocardiography.
(2) biochemical indicator: Angiotensin II (Ang II), transforminggrowthfactor-β1 (TGF β 1), superoxide dismutase (SOD), serum II I procollagen type amino terminal peptide (PIII NP), aldosterone (ALD) detects AngII, PIIINP, ALD.
(3) qi depression to blood stasis integration: symptom by without, light, in, heavy degree remembers respectively 0,1,2,3 points.
Cardiac function detects, biochemical indicator is healing in normal range; , obviously improve, approaching normal for taking a turn for the better, invalid without being improved as.Qi depression to blood stasis integration, transference cure is for curing, and symptom obviously alleviates as taking a turn for the better, invalid without being improved as.
Embodiment 5: clinical observation and curative effect
This group case is the 86 routine AMI patients that in June, 2011 to 2013, year Hebi City in July the People's Hospital Cardiological was accepted for medical treatment, and 86 examples all meet syndrome of qi stagnation and blood stasis diagnostic criteria, are divided into observation group and each 43 examples of matched group by table of random number.The male of observation group 25 examples, women's 18 examples; Year at age (62.4 ± 7.3); Matched group male 26 examples, women's 17 examples; Year at age (61.4 ± 7.1).Relatively no difference of science of statistics of two groups of patient's physical data, has comparability.
Syndrome of qi stagnation and blood stasis diagnostic criteria: formulate with reference to " obstruction of qi in the chest and cardialgia (angina pectoris) anxious card diagnosis and treatment specification ", receive people's standard: 1. meet the Diagnosis of Acute Myocardial Infarction standard that myocardial ischemia, ST section are raised; 2. meet syndrome of qi stagnation and blood stasis diagnostic criteria; 3. NYHA cardiac function I～III level; 4. age <75 year; 5. obtain informed consent.
We treat 43 examples altogether, and through 2 months medication treatments, clinical cure 25 examples accounted for 58%, and effective 16 examples account for 37%, and invalid 2 examples account for 5%, total effective rate 95%.Treat forward and backward parameters of left ventricular function comparison for two groups: the LVDd of observation group after treatment, LVEDV, LVSDV, CI and LVEF all obviously improve (P<0.05 before treatment, P<0.01), matched group LVEDV, LVSDV and LVEF improve (P<0.05, P<0.01) before treating; The improvement of the LVEDV of observation group and LVEF is better than matched group (P<0.05).
Embodiment 6: patient proves
Patient, man, 65 years old, suffer from coronary heart disease for many years, myasthenia of limbs, heart often twists pain, myocardial ischemia, with Western medicine transfusion, 1 year twice, without improve at all.Take this formula three months, blood fat obviously improves, and after six months, heart tends to be steady, and heart does not also ache, and takes and within 1 year, has no rebound phenomenon, and chemical examination is still normal so far.
Patient, man, 52 years old, suffer from coronary heart disease, myocardial ischemia, dizziness heart beating 4 years, distressed fixed through informal dress, the heart is precious, the medicines such as Radix Salviae Miltiorrhizae drop pill, without improve at all, take this formula, and dizziness heart beating in six months is steady, has no rebound phenomenon.
Patient, female, 72 years old, suffer from coronary heart disease, myocardial ischemia, the large finger of hands and inferior finger numbness, can not hold thing, and twice prevention of transfusion in a year, without improve at all, takes this formula, and within eight months, blood pressure is steady, and pain and numbness disappears, and has no rebound phenomenon.
Claims (2)
1. a medicine for treatment coronary heart disease, is characterized in that the amounts of components of this medicine is: Radix Panacis Quinquefolii 4-8g, Radix Astragali 18-22g, Radix Salviae Miltiorrhizae 13-17g, Hirudo 1-5g, Styrax 0.1-0.5g, Exocarpium Citri Rubrum 8-12g, Bulbus Allii Macrostemonis 8-12g, Semen Armeniacae Amarum 8-12g, Fructus Trichosanthis 28-32g, Rhizoma Pinelliae 1-5g, Rhizoma Chuanxiong 13-17g, Radix Angelicae Sinensis 10-14g, Rhizoma Cyperi 10-14g and Radix Curcumae 8-12g; Its processing technology is: said medicine is put into medicine pot, add water and must exceed medicine top levels 3cm, soak 1 hour, start to boil, first use big fire boiled, then boil 40 minutes with little fire, medicinal liquid is leached, endure out medicinal liquid 200ml first.Again add water and exceed medicine top levels 2cm, boil, boil 20 minutes time, leach medicinal liquid 200ml, twice medicinal liquid mixed, add Styrax 0.2-0.4g, stir finished product, in last filling and package bag, cold preservation warehouse-in.
2. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that the amounts of components of described medicine is: Radix Panacis Quinquefolii 6g, Radix Astragali 20g, Radix Salviae Miltiorrhizae 15g, Hirudo 3g, Styrax 0.3g, Exocarpium Citri Rubrum 10g, Bulbus Allii Macrostemonis 10g, Semen Armeniacae Amarum 10g, Fructus Trichosanthis 30g, Rhizoma Pinelliae 3g, Rhizoma Chuanxiong 15g, Radix Angelicae Sinensis 12g, Rhizoma Cyperi 12g and Radix Curcumae 10g; Its processing technology is: said medicine is put into medicine pot, add water and must exceed medicine top levels 3cm, soak 1 hour, start to boil, first use big fire boiled, then boil 40 minutes with little fire, medicinal liquid is leached, endure out medicinal liquid 200ml first.Again add water and exceed medicine top levels 2cm, boil, boil 20 minutes time, leach medicinal liquid 200ml, twice medicinal liquid mixed, add Styrax 0.3g, stir finished product, in last filling and package bag, cold preservation warehouse-in.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410100271.4A CN103893694B (en) | 2014-03-11 | 2014-03-11 | A kind of medicine for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410100271.4A CN103893694B (en) | 2014-03-11 | 2014-03-11 | A kind of medicine for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103893694A true CN103893694A (en) | 2014-07-02 |
| CN103893694B CN103893694B (en) | 2017-06-06 |
Family
ID=50985478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410100271.4A Expired - Fee Related CN103893694B (en) | 2014-03-11 | 2014-03-11 | A kind of medicine for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103893694B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111437358A (en) * | 2019-01-16 | 2020-07-24 | 辽宁中医药大学 | Traditional Chinese medicine composition for treating atherosclerosis caused by phlegm-turbidity and blood stasis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593489A (en) * | 2004-07-02 | 2005-03-16 | 李东林 | Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof |
| WO2012135498A2 (en) * | 2011-03-29 | 2012-10-04 | Dr. Baker Says, Inc. | Nutritional supplement comprising nut and seed oil composition |
-
2014
- 2014-03-11 CN CN201410100271.4A patent/CN103893694B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593489A (en) * | 2004-07-02 | 2005-03-16 | 李东林 | Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof |
| WO2012135498A2 (en) * | 2011-03-29 | 2012-10-04 | Dr. Baker Says, Inc. | Nutritional supplement comprising nut and seed oil composition |
Non-Patent Citations (2)
| Title |
|---|
| 金丽: ""从一病一基本方"谈辨病与辨证相结合", 《甘肃中医》 * |
| 陶克文: "胸痹心痛证治体会", 《实用中医药杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111437358A (en) * | 2019-01-16 | 2020-07-24 | 辽宁中医药大学 | Traditional Chinese medicine composition for treating atherosclerosis caused by phlegm-turbidity and blood stasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103893694B (en) | 2017-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103330805B (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN104758587A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN104740289A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN103316204A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN104547939A (en) | Traditional Chinese medicine preparation for treating premature beat | |
| CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
| CN103919910A (en) | Medicine for treating coronary heart disease | |
| CN103007192B (en) | Chinese medicinal composition for treating thoracic obstruction | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103893694A (en) | Medicine for treating coronary heart diseases | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN102784234A (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
| CN104645223A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
| CN105477330A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN105343518A (en) | Traditional Chinese medicine formula for treating chronic aplastic anemia and preparation method thereof | |
| CN104173934A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103211904A (en) | Medicament for treating hypotension | |
| CN105663659A (en) | Traditional Chinese medicinal composition for treating constipation | |
| CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170606 Termination date: 20190311 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |